Beyond BCa, the development of STK3 inhibitors to mitigate the effects of chemotherapy may have a broad impact, such as in childhood cancer survivors who are seven times more likely to die prematurely from cardiac disease than the general population [39]. Here, STK3 is linked to cancer.